Dimensional Fund Advisors’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.04M | Buy |
|
|||||
|
2025
Q1 | $662K | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $20M | Sell |
|
|||||
|
2024
Q2 | $24.5M | Sell |
|
|||||
|
2024
Q1 | $30M | Sell |
|
|||||
|
2023
Q4 | $23.5M | Sell |
|
|||||
|
2023
Q3 | $22.2M | Buy |
|
|||||
|
2023
Q2 | $9.35M | Buy |
|
|||||
|
2023
Q1 | $7.22M | Sell |
|
|||||
|
2022
Q4 | $9.31K | Sell |
|
|||||
|
2022
Q3 | $10.5M | Sell |
|
|||||
|
2022
Q2 | $10.3M | Buy |
|
|||||
|
2022
Q1 | $10.7M | Buy |
|
|||||
|
2021
Q4 | $9.81M | Buy |
|
|||||
|
2021
Q3 | $6.55M | Buy |
|
|||||
|
2021
Q2 | $3.49M | Buy |
|
|||||
|
2021
Q1 | $1M | Buy |
|
|||||
|
2020
Q4 | $337K | Buy |
|